Pharma has long marketed opioids in ways that contribute to opioid use disorder and deaths by overdose. Regulatory mistakes in approving and labeling new analgesics by the FDA didn’t make us safer.
AMA J Ethics. 2020;22(8):E743-750. doi:
10.1001/amajethics.2020.743.
Upcoding and misrepresenting clinical information constitute fraud, cost a lot, and can result in patient harm and unnecessary procedures and prescriptions.
AMA J Ethics. 2020;22(3):E221-231. doi:
10.1001/amajethics.2020.221.
Dr Susan Veldheer joins Ethics Talk to discuss her article, coauthored with Dr Daniel R. George: "Strategies to Help Health Care Organizations Execute Their Food System Leadership Responsibilities.”
Conflicts of interest must be acknowledged with sincerity and earnestness and managed such that the conflict is eliminated or, at least, credibly mitigated.
AMA J Ethics. 2023;25(3):E186-193. doi:
10.1001/amajethics.2023.186.